INVESTOR RELATIONS

FINANCIAL NEWS (PRESS RELEASES)

FINANCIAL NEWS (PRESS RELEASES)

There are currently no events to display.
Date Title
11/21/17
Summary ToggleViewRay® to Participate in Upcoming Conferences CLEVELAND , Nov. 21, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to participate in two upcoming investor conferences. The first conference is the 29th Annual Piper Jaffray Printer Friendly Version
11/13/17
Summary ToggleViewRay Reports Third Quarter 2017 Financial Results Strong Order Momentum in Q3, continuing in Q4 CLEVELAND , Nov. 13, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the third quarter and nine months ended September 30, 2017 . Third Quarter & Recent Financial Highlights: Total revenue of $12.2 million in Q3 Printer Friendly Version
11/10/17
Summary ToggleWashington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System from ViewRay Greater Assurance in Tumor Targeting Drives Expansion of MR-Guided Radiation Therapy Program CLEVELAND , Nov. 10, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Printer Friendly Version
11/09/17
Summary ToggleViewRay® to Present at the Stifel 2017 Healthcare Conference CLEVELAND , Nov. 9, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to present at the Stifel 2017 Healthcare Conference. Event:           Stifel 2017 Healthcare Conference Date:  Printer Friendly Version
11/08/17
Summary ToggleViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017 CLEVELAND , Nov. 8, 2017 /PRNewswire/ --   ViewRay, Inc. (Nasdaq:  VRAY ) announced today details relating to the release of its third quarter 2017 financial results, which will take place on Monday, November 13, 2017 before market open. ViewRay will hold a conference call on Monday, November 13, Printer Friendly Version
11/03/17
Summary ToggleViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender Top Cancer Centers to Bring Benefits of MR-Guided Soft-tissue Visualization and Adaptive Treatment Delivery to Copenhagen CLEVELAND , Nov. 3, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® Linac has been selected for installation at Rigshospitalet and Printer Friendly Version
10/24/17
Summary ToggleViewRay Raises $50 Million through Sale of Common Stock Financing to Support Ongoing Commercialization of MRIdian Linac CLEVELAND , Oct. 24, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has raised aggregate gross proceeds of approximately $50 Printer Friendly Version
10/17/17
Summary ToggleEarly Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with MRIdian MR-Guided Radiation Therapy Study Indicates Higher Dosing Enabled by MR-guidance Combined with Daily On-table Adaptation Led to Significant Potential Clinical Benefits for Pancreatic Cancer Patients CLEVELAND , Oct. 17, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided Printer Friendly Version
09/25/17
Summary ToggleViewRay Launches Clinical Trial Following Compelling Early Pancreatic Cancer Data with MRIdian System First Initiative Based on Retrospective Study That Suggests Potential for Significantly Prolonged Survival CLEVELAND , Sept. 25, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today the launch of a multi-center prospective clinical trial for locally advanced unresectable pancreatic Printer Friendly Version
09/21/17
Summary ToggleViewRay MRIdian to be Featured in 21 Presentations from Seven Leading Centers at ASTRO ViewRay to Host Inaugural Clinical Cooperative Think Tank Meeting to Advance MR-Guided Radiation Therapy Research CLEVELAND , Sept. 21, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian and MRIdian Linac systems will be featured at the Annual Meeting of Printer Friendly Version
09/20/17
Summary ToggleViewRay® to Host Analyst & Investor Meeting at ASTRO in San Diego CLEVELAND , Sept. 20, 2017 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investors on Monday, September 25, 2017 , during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego . Printer Friendly Version
09/06/17
Summary ToggleViewRay® to Participate in Morgan Stanley Global Healthcare Conference CLEVELAND , Sept. 6, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York, NY . Printer Friendly Version
08/07/17
Summary ToggleViewRay Reports Second Quarter 2017 Financial Results On Track to Achieve 2017 Financial Guidance CLEVELAND , Aug. 7, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter and six months ended June 30, 2017 . Second Quarter 2017 Highlights: Received record quarterly new orders for MRIdian Linac Printer Friendly Version
08/03/17
Summary ToggleEarly Clinical Experience with ViewRay's MRIdian Linac Presented at Leading Medical Physics Meeting AAPM Talks Highlight Clinical Value of MRIdian On-Table Adaptive Therapy for Escalating Target Dose and Avoiding Nearby Organs at Risk CLEVELAND , Aug. 3, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today highlights from the 2017 Annual Meeting of the American Association of Printer Friendly Version
08/01/17
Summary ToggleViewRay Announces Conference Call and Webcast of Second Quarter 2017 Financial Results to be Held on August 7, 2017 CLEVELAND , Aug. 1, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2017 financial results, which will take place on Monday, August 7, 2017 after market close. ViewRay will hold a conference call on Monday, August 7, 2017 at Printer Friendly Version
07/21/17
Summary ToggleLeading Medical Physics Meeting to Feature First Presentations on Clinical Experience with ViewRay's MRIdian Linac 30 Presentations Highlight MRIdian's Growing Role in Cancer Care CLEVELAND , July 21, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA -cleared MRI-guided radiation therapy system with linear accelerator-based delivery, announced today that the company's MRIdian® Printer Friendly Version
07/20/17
Summary ToggleFirst Patients Treated with ViewRay's MRIdian Linac System at Henry Ford Health System World's First FDA-Cleared MRI-guided Linear Accelerator-based Radiation Therapy System Now Treating Patients CLEVELAND , July 20, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the first cancer patients have been treated using the company's MRIdian Linac system at Henry Printer Friendly Version
06/26/17
Summary ToggleNational Cancer Center Japan Treats First Patients Using ViewRay MRIdian System Printer Friendly Version
06/13/17
Summary ToggleViewRay® to Present at The JMP Securities Life Sciences Conference Printer Friendly Version
05/30/17
Summary ToggleViewRay® to Present at Citi's 2017 Small & Mid Cap Conference Printer Friendly Version
05/15/17
Summary ToggleViewRay Reports First Quarter 2017 Financial Results Printer Friendly Version
05/15/17
Summary ToggleCompelling Early Pancreatic Cancer Data with ViewRay's MRIdian System Presented at ESTRO 36 Printer Friendly Version
05/10/17
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2017 Printer Friendly Version
05/02/17
Summary ToggleViewRay Showcases World's First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology Meeting Printer Friendly Version
04/13/17
Summary ToggleViewRay Announces $15.0 Million Capacity Expansion of its Term Loan Agreement Printer Friendly Version
03/16/17
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2016 Financial Results Printer Friendly Version
03/14/17
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2016 Financial Results to be Held on March 16, 2017 Printer Friendly Version
02/27/17
Summary ToggleViewRay Receives FDA 510(k) Clearance for MRIdian Linac Printer Friendly Version
02/22/17
Summary ToggleViewRay® to Participate in Upcoming Conferences Printer Friendly Version
01/24/17
Summary TogglePrivate Japanese Hospital Purchases ViewRay MRIdian System Printer Friendly Version
01/19/17
Summary ToggleGerman Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg Printer Friendly Version
01/18/17
Summary ToggleViewRay Raises $26.1 Million in Private Placement Printer Friendly Version
11/30/16
Summary TogglePublished Study Highlights MRIdian System's Value in Sparing Healthy Tissue from Radiation Printer Friendly Version
11/14/16
Summary ToggleViewRay Reports Third Quarter 2016 Financial Results Printer Friendly Version
11/07/16
Summary ToggleViewRay to Present at the Stifel 2016 Healthcare Conference Printer Friendly Version
11/07/16
Summary ToggleViewRay Announces Conference Call and Webcast of Third Quarter 2016 Financial Results to be Held on November 14, 2016 Printer Friendly Version
10/13/16
Summary ToggleMRIdian Clinical Outcomes Data and Adaptive Capabilities: Highlights from ASTRO 2016 Printer Friendly Version
09/22/16
Summary ToggleViewRay MRIdian Clinical Experience to be highlighted by Five Leading Centers at Largest Radiation Oncology Meeting Printer Friendly Version
09/21/16
Summary ToggleNational Cancer Center Japan Purchases ViewRay MRIdian System Printer Friendly Version
09/19/16
Summary ToggleViewRay Receives CE Mark Approval for its MRIdian Linac System Printer Friendly Version
09/09/16
Summary ToggleViewRay Receives Chinese Regulatory Approval for its MRIdian System Printer Friendly Version
09/06/16
Summary ToggleViewRay to Present at the 18th Annual Rodman & Renshaw Global Investment Conference Printer Friendly Version
09/01/16
Summary ToggleHenry Ford to Acquire ViewRay MRIdian Linac Research System Printer Friendly Version
08/19/16
Summary ToggleViewRay Announces $13.75 Million Private Placement Printer Friendly Version
08/15/16
Summary ToggleViewRay Reports Second Quarter 2016 Financial Results Printer Friendly Version
08/15/16
Summary ToggleViewRay's MRIdian System Receives Japanese Regulatory Approval (Shonin) Printer Friendly Version
08/08/16
Summary ToggleFirst Scientific Presentations on ViewRay's MRIdian Linac Technology Printer Friendly Version
08/04/16
Summary ToggleViewRay Announces Conference Call and Webcast of Second Quarter 2016 Printer Friendly Version
07/28/16
Summary ToggleLeading Medical Physics Meeting to Feature 40 Presentations on ViewRay's MRIdian System Printer Friendly Version
06/27/16
Summary ToggleViewRay® Added to Russell 3000, Russell Global and Russell Microcap Indexes Printer Friendly Version
06/09/16
Summary ToggleViewRay® Appoints Ajay Bansal as Chief Financial Officer Printer Friendly Version
05/13/16
Summary ToggleViewRay Reports First Quarter 2016 Financial Results Printer Friendly Version
05/09/16
Summary ToggleRadiosurgery Society® Webinar Features UCLA Doctors Discussing Clinical Experience with ViewRay's MRIdian System Printer Friendly Version
05/06/16
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2016 Financial Results to be Held on May 13, 2016 Printer Friendly Version
04/28/16
Summary ToggleViewRay's MRI-Guided Radiation Therapy System to be featured at Leading European Radiation Oncology Meeting Printer Friendly Version
04/18/16
Summary ToggleTreatment with ViewRay's MRI-Guided Radiation Therapy Now Available on the U.S. East Coast Printer Friendly Version
04/12/16
Summary ToggleViewRay® Appoints Dr. Henry A. McKinnell, Jr. to its Board of Directors Printer Friendly Version
03/28/16
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2015 Financial Results and Up-listing to the NASDAQ Global Market Printer Friendly Version
03/24/16
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2015 Financial Results to be Held on March 28, 2016 Printer Friendly Version
03/24/16
Summary ToggleFirst MRIdian System Installed in Europe at VU University Medical Center of Amsterdam Printer Friendly Version
03/14/16
Summary ToggleWashington University Acquires ViewRay Research System to Investigate MRI-Guided Linac Capabilities Printer Friendly Version
03/08/16
Summary ToggleViewRay to Present at the 28th Annual ROTH Conference Printer Friendly Version
03/02/16
Summary ToggleViewRay to Present at the 36th Annual Cowen Health Care Conference Printer Friendly Version
02/19/16
Summary ToggleFox Business Network Varney & Co. Interview with ViewRay CEO Chris Raanes Printer Friendly Version
01/11/16
Summary ToggleWorld's First MRIdian Center Celebrates Two Years of MRI-Guided Radiation Treatments Printer Friendly Version
12/29/15
Summary ToggleViewRay® Appoints Brian K. Roberts to its Board of Directors Printer Friendly Version
12/16/15
Summary ToggleViewRay CEO interviewed on Stock News Now Printer Friendly Version
11/24/15
Summary ToggleViewRay® to Present at the LD Micro “Main Event” Microcap Conference Printer Friendly Version
11/12/15
Summary ToggleViewRay® to Present at the Stifel 2015 Healthcare Conference Printer Friendly Version
11/09/15
Summary ToggleViewRay Reports Third Quarter 2015 Financial Results Printer Friendly Version
10/18/15
Summary ToggleViewRay® Receives Regulatory Approval to Sell MRI-Guided Radiation Therapy System in Korea Printer Friendly Version
10/15/15
Summary ToggleMRIdian® Clinical Experience and Faster, Higher-Resolution Imaging to be featured at Largest Radiation Oncology Meeting Printer Friendly Version
10/13/15
Summary ToggleViewRay® Receives 2015 Frost & Sullivan Technology Innovation Leadership Award Printer Friendly Version
09/15/15
Summary ToggleViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital Printer Friendly Version
09/02/15
Summary ToggleRadiosurgery Society® Webinar on MR-Guided Stereotactic Body Radiation Therapy Yields Record Attendance Printer Friendly Version
08/19/15
Summary ToggleViewRay® (VRAY) Completes Private Placement, Raises Aggregate of $29.4 Million Printer Friendly Version
07/23/15
Summary ToggleViewRay Completes Alternative Public Offering, Raises $26.7 Million Printer Friendly Version
07/09/15
Summary ToggleViewRay's MRIdian System to be featured at Leading Medical Physics Meeting Printer Friendly Version
06/30/15
Summary ToggleViewRay Secures Up To $50M in Debt Financing From CRG Printer Friendly Version
04/23/15
Summary ToggleViewRay to Showcase World's Only Commercially Available MRI-Guided Radiation Therapy System at Leading European Radiation Oncology Meeting Printer Friendly Version
02/03/15
Summary ToggleViewRay Receives First European Order for its MRIdian System Printer Friendly Version
01/22/15
Summary ToggleItochu Named the Exclusive Distributor for Viewray's MRI-Guided Radiation Therapy System in Japan Printer Friendly Version
11/11/14
Summary ToggleViewRay MRIdian System Receives CE Mark Printer Friendly Version
09/12/14
Summary ToggleViewRay to Showcase World’s Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting Printer Friendly Version
09/10/14
Summary ToggleUniversity of Wisconsin Carbone Cancer Center Becomes First in the World to Treat Patients with MRIdian’s Soft-Tissue-Tracking-Beam Control Printer Friendly Version
09/09/14
Summary ToggleViewRay’s MRIdian Makes Adaptive Radiation Therapy a Clinical Reality Printer Friendly Version
07/31/14
Summary ToggleRevolutionary Radiation Therapy System from ViewRay is Acquired by Sylvester Comprehensive Cancer Center at the University of Miami Printer Friendly Version
07/18/14
Summary ToggleViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting Printer Friendly Version
02/05/14
Summary ToggleViewRay™ Announces World’s First Patients Treated Using MRI-Guided Radiation Therapy Printer Friendly Version
12/17/13
Summary ToggleViewRay™ Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System Printer Friendly Version
05/30/13
Summary ToggleViewRay’s Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO) Printer Friendly Version
02/04/13
Summary ToggleViewRay Appoints Chris A. Raanes President and CEO Printer Friendly Version
07/11/12
Summary ToggleSiteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with ViewRay System Printer Friendly Version
05/30/12
Summary ToggleViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System Printer Friendly Version
03/20/12
Summary ToggleViewRay Names Michael Brandt Senior Vice President of Sales Printer Friendly Version
03/13/12
Summary ToggleViewRay Closes Round of Series C Financing Printer Friendly Version
09/29/11
Summary ToggleViewRay Demonstrates Potential Therapy Applications for MRI-Guided Radiation at ASTRO 2011 Printer Friendly Version
09/27/11
Summary ToggleUCLA Health System – Jonsson Comprehensive Cancer Center to Acquire ViewRay System Printer Friendly Version
05/24/11
Summary ToggleViewRay Earns TiE50 Award Printer Friendly Version
05/18/11
Summary ToggleLandmark Patents Issued for ViewRay Technology Printer Friendly Version
03/09/11
Summary ToggleUniversity of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System Printer Friendly Version
02/23/11
Summary ToggleViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software Printer Friendly Version
10/29/10
Summary ToggleViewRay Introduces Vision for MRI-Guided Radiotherapy at ASTRO 2010 Printer Friendly Version
08/25/10
Summary ToggleViewRay Secures Series C Financing Printer Friendly Version
08/03/10
Summary ToggleSiteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay System Printer Friendly Version
02/16/10
Summary ToggleViewRay Wins NorTech Innovation Award Printer Friendly Version
04/21/09
Summary ToggleViewRay Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG Printer Friendly Version
01/21/08
Summary ToggleViewRay Incorporated Raises $25 Million in Series B Financing Printer Friendly Version
Copyright 2017 © ViewRay. All rights reserved